Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Spectrum Taps Proscia to Modernize its Pathology Operations

Proscia
By Author Proscia | March 13, 2023

As Spectrum Healthcare Partners serves patients across various healthcare systems, it recognized an opportunity to pioneer the use of digital pathology in its region to expand the reach of its subspecialist experts and deliver timely results. It is adopting Proscia’s Concentriq Dx* to modernize its operations.

*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency. 

Our website uses cookies. By using this site, you agree to its use of cookies.